BioInvent cuts jobs as it ceases contract manufacturing
This article was originally published in Scrip
Executive Summary
BioInvent is to cut around 13% of its staff as it refocuses operations by tailoring its process development and manufacturing resources to proprietary product development. As a result it will cease contract manufacturing.